Guo L A, Wang L M, Fu Y J, Luo T, Fan X T, Zhao L H, Yao X H, Piao Y S
Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing Geriatric Medical Research Centre, Beijing 100053, China.
Department of Pathology, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Zhonghua Bing Li Xue Za Zhi. 2024 Jun 8;53(6):585-591. doi: 10.3760/cma.j.cn112151-20231227-00444.
To investigate the clinical, radiological, and pathological features of anaplastic gangliogliomas (AGGs) and to determine whether these tumors represent a distinct entity. Consecutive 667 cases of ganglioglioma (GG) diagnosed at the Xuanwu Hospital, Capital Medical University, Beijing, China between January 2015 and July 2023 were screened. Among these cases, 9 pathologically confirmed AGG cases were identified. Their clinical, radiological, treatment, and outcome data were analyzed retrospectively. Most of the tumor samples were subject to next-generation sequencing, while a subset of them were subject to DNA methylation profiling. Among the 9 patients, there were five males and four females, with a median age of 8 years. Epileptic seizures (5/9) were the most frequently presented symptom. Radiological examinations showed three types of radiological manifestations: four cases showed abnormal MRI signals with no significant mass effects and mild enhancement; two cases demonstrated a mixed solid-cystic density lesion with peritumoral edema, which showed significant heterogeneous enhancement and obvious mass effects, and one case displayed cystic cavity formation with nodules on MRI, which showed evident enhancements. All cases exhibited mutations that were predicted to activate the MAP kinase signaling pathway, including seven with BRAF p.V600E mutation and two with NF1 mutation. Five AGGs with mutations involving the MAP kinase signaling pathway also had concurrent mutations, including three with CDKN2A homozygous deletion, one with a TERT promoter mutation, one with a H3F3A mutation, and one with a PTEN mutation. AGG exhibits a distinct spectrum of pathology, genetic mutations and clinical behaviors, differing from GG. Given these characteristics suggest that AGG may be a distinct tumor type, further expansion of the case series is needed. Therefore, a comprehensive integration of clinical, histological, and molecular analyses is required to correctly diagnose AGG. It will also help guide treatments and prognostication.
探讨间变性节细胞胶质瘤(AGGs)的临床、影像学和病理特征,并确定这些肿瘤是否代表一种独特的实体。对2015年1月至2023年7月在中国北京首都医科大学宣武医院确诊的667例连续性节细胞胶质瘤(GG)病例进行筛选。在这些病例中,确定了9例经病理证实的AGG病例。对其临床、影像学、治疗和结局数据进行回顾性分析。大多数肿瘤样本进行了二代测序,而其中一部分进行了DNA甲基化分析。9例患者中,男性5例,女性4例,中位年龄8岁。癫痫发作(5/9)是最常见的症状。影像学检查显示三种影像学表现:4例MRI信号异常,无明显占位效应,轻度强化;2例表现为混合实性囊性密度病变,伴有瘤周水肿,呈明显不均匀强化和明显占位效应,1例MRI显示有结节的囊腔形成,呈明显强化。所有病例均表现出预测可激活MAP激酶信号通路的突变,包括7例BRAF p.V600E突变和2例NF1突变。5例涉及MAP激酶信号通路突变的AGGs也有并发突变,包括3例CDKN2A纯合缺失、1例TERT启动子突变、1例H3F3A突变和1例PTEN突变。与GG不同,AGG表现出独特的病理、基因突变和临床行为谱。鉴于这些特征表明AGG可能是一种独特的肿瘤类型,需要进一步扩大病例系列。因此,需要综合临床、组织学和分子分析来正确诊断AGG。这也将有助于指导治疗和预后评估。